Specialty Pharmacy

HIV patients not on recommended regimens are less likely to achieve viral suppression and more likely to report side effects.

BRD4 gene could be exploited in treatment of acute myeloid leukemia.

MS prevalence increases in areas of higher latitude with decreased levels of sunlight exposure.

The National Institutes of Health (NIH) has awarded universities about $28 million in grants to study pediatric asthma triggers.

The FDA is considering expanding the use of Allergen's skin infection drug dalbavancin (Dalvance).

Did you know that the 14% of undiagnosed HIV patients cause 33% of new infections?

Exposure to benzene due to high traffic volume during childhood may contribute to disease development.

Top news of the week in cancer drug development.

Vitamin D deficiency may speed progression of the condition.

Opdivo was previously approved for patients with squamous NSCLC whose disease progressed during or after platinum-based chemotherapy.

The FH Foundation helps guide patients on their journey to battle a silent killer.

Top stories of the week on Specialty Pharmacy Times.

Several genetic characteristics of more aggressive tumors significantly more prevalent in the African American community.

Roflumilast normally treats inflammatory lung diseases, but was found to dramatically inhibit tumor growth.

Contaminated dairy and beef with bovine leukemia virus may contribute to cancer development.

MS-related inflammation may affect fertility.

The FDA is considering expanding the use for a drug currently indicated as a chronic hepatitis C (HCV) treatment.

Health information sharing web site helps connect patients among more than 2500 conditions.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the growth of the annual NASP Specialty Pharmacy Conference, held from Sept. 29 through Oct. 1, 2015.

Tecfidera reduces annualized MS relapse rate by 63% compared with placebo.

Vaginal rings show promise for administering medication and preventing the spread of sexual transmitted infections.

Study findings may change the development of cancer therapy.

Varying prevalence of fatigue from RA has been reported due to differences in definitions and measures.

FOXC1 gene is needed to turn cells into specialized tissues such as the eyes, kidney, brain, and bone.

No OTC products for sale and few customers coming in with prescriptions to fill were 2 reasons why a pharmacy in California seemed suspicious.

The FDA's Office of Generic Drugs (OGD) will no longer require final printed labeling to approve Abbreviated New Drug Applications (ANDAs).

The FDA has approved a new treatment combination of Gilead's ambrisentan (Letairis) with tadalafil to treat pulmonary arterial hypertension.

Medical Marijuana Advocates Group helps patients access care through programs that lower the cost of seeing a physician.